Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Femasys (FEMY)
NASDAQ:FEMY
FEMY Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.86 - $2.40
Previous CloseN/A
Volume25.00K
Average Volume (3M)383.84K
Market Cap
$40.53M
Enterprise Value$24.30M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-1.47
Next Earnings
Mar 27, 2025EPS Estimate
-0.19Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.82
Shares Outstanding22,898,468
10 Day Avg. Volume766,005
30 Day Avg. Volume383,844
Standard Deviation0.93
R-Squared0.02
Alpha0.11
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)30.96
Price to Cash Flow (P/CF)-1.80
P/FCF Ratio0.00
Enterprise Value/Market Cap0.60
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit35.13
Enterprise Value/Ebitda-1.53
Forecast
1Y Price Target
$12.00Price Target Upside577.97% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
---
Bulls Say, Bears Say
Bulls Say
International ExpansionApprovals of FemaSeed in U.K. and Israel expand company's ex-U.S. commercial footprint ability, potentially leading to additional streams of revenue.
PartnershipsThe partnership with Boston IVF opens up commercial access to 30 fertility centers in the Northeast, and product ordering has already begun.
Product LaunchInitial sales of FemaSeed were higher than initial estimates, showcasing positive initial launch efforts.
Bears Say
FinancialsFemasys ended 3Q24 with $7.6M in cash and cash equivalents, estimated to fund operations into 2H25, which may indicate potential financial pressure if revenue growth does not meet expectations.
Market CompetitionDespite the positive reception, FemaSeed enters a competitive market where established treatments like IUI are already widely used.
Regulatory ChallengesWhile the company has secured EU Medical Device Regulation certification and CE Mark for four products, navigating regulatory landscapes in various countries can pose challenges.
---
Ownership Overview
5.39%
Insiders
1.68% Mutual Funds
4.52% Other Institutional Investors
84.80% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
FEMY FAQ
What was Femasys’s price range in the past 12 months?
Femasys lowest stock price was $0.86 and its highest was $2.40 in the past 12 months.
What is Femasys’s market cap?
Femasys’s market cap is $40.53M.
When is Femasys’s upcoming earnings report date?
Femasys’s upcoming earnings report date is Mar 27, 2025 which is in 33 days.
How were Femasys’s earnings last quarter?
Femasys released its earnings results on Nov 12, 2024. The company reported -$0.24 earnings per share for the quarter, missing the consensus estimate of -$0.2 by -$0.04.
Is Femasys overvalued?
According to Wall Street analysts Femasys’s price is currently Undervalued.
Does Femasys pay dividends?
Femasys does not currently pay dividends.
What is Femasys’s EPS estimate?
Femasys’s EPS estimate is -0.19.
How many shares outstanding does Femasys have?
Femasys has 22,898,468 shares outstanding.
What happened to Femasys’s price movement after its last earnings report?
Femasys reported an EPS of -$0.24 in its last earnings report, missing expectations of -$0.2. Following the earnings report the stock price went down -11.207%.
Which hedge fund is a major shareholder of Femasys?
Currently, no hedge funds are holding shares in FEMY
---
Femasys Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$12.00 (577.97% Upside)
$12.00 (577.97% Upside)
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.7%
Last 30 Days ▼ 6.5%
Last 30 Days ▼ 6.5%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
43.90%
12-Months-Change
Fundamentals
Return on Equity
-220.59%
Trailing 12-Months
Asset Growth
4.92%
Trailing 12-Months
Company Description
Femasys
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. Its mission is to provide women with minimally-invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics.
---
FEMY Stock 12 Month Forecast
Average Price Target
$12.00
▲(577.97% Upside)
Technical Analysis
Best Analysts Covering FEMY
1 Year
1 Year Success Rate
9/14 ratings generated profit
1 Year Average Return
+19.75%
reiterated a buy rating 3 months ago
Copying Keay Nakae's trades and holding each position for 1 Year would result in 64.29% of your transactions generating a profit, with an average return of +19.75% per trade.
---